[1] Zhou M G, Wang H D, Zeng X Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158.
[2] Wang W Z, Jiang B, Sun H X, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults[J]. Circulation, 2017, 135(8): 759-771.
[3] 《中国脑卒中防治报告》编写组. 《中国脑卒中防治报告2019》概要[J]. 中国脑血管病杂志, 2020, 17(5): 272-281.
[4] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J] . 中华神经科杂志, 2018, 51(9) : 666-682.
[5] 刘新峰, 叶瑞东.《中国急性缺血性脑卒中早期血管内介入诊疗指南2018》制订感想[J]. 中华神经科杂志, 2018, 51(9): 660-663.
[6] 王陇德,吉训明, 康德智, 等. 《中国卒中中心报告2020》概要[J]. 中国脑血管病杂志, 2021, 18(11): 737-743.
[7] Sun F, Liu H, Fu H X, et al. Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction[J]. J Int Med Res, 2020, 48(5): 300060519895352.
[8] 辜蕊, 李蓉, 李立, 等. 不同脑卒中评估工具对急性大血管闭塞性脑梗死的预测价值[J]. 中华老年心脑血管病杂志, 2021, 23(1): 51-54.
[9] 辜蕊, 李蓉, 唐卉, 等. 急性大血管闭塞性脑梗死的危险因素分析[J]. 临床神经病学杂志, 2020, 33(4): 254-258.
[10] Li F F, Ma Q F, Li L Z, et al. Alterations of inflammatory cytokines in super-acute stroke patients and the potential pathogenesis[J]. J Clin Neurosci, 2022, 99: 35-43.
[11] Montellano F A, Ungethüm K, Ramiro L, et al. Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review[J]. Stroke, 2021, 52(2): 543-551.
[12] Wang Y, Zhang J, Dai L, et al. Leukocyte counts and ratios as potential predictors of large vessel occlusion in acute ischemic stroke: a retrospective cohort study[J]. Medicine, 2024, 103(16): e37904.
|